Gimsilumab

Tax included
Gimsilumab (MORAb-022) is a humanized anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA).
MedChemExpress 
HY-P99642

Data sheet

Size
Multiple sizes
Reactivity
c-Fms; SARS-CoV
CAS
1648796-29-5